We studied the Interstitial fluid concentration of two llpld-metabollzing enzymes (lipoprotein lipase and hepatic triacylglycerol lipase) to determine their Importance in Interstitial modification of filtered llpoprotelns. Despite the use of a very sensitive lipase assay (1 nmol of fatty acid release/ml/hr), lipase activities in plasma and In peripheral and skeletal muscle lymph from control dogs were below the sensitivity of our assay. After heparin Injection, hepatic triacylglycerol lipase and lipoprotein lipase activities In plasma were similar. However, the postheparin hepatic triacylglycerol lipase activities in peripheral and skeletal muscle lymph were only 1.4% and 1.1%, respectively, those of plasma. This concentration Is considerably less than the lymph concentration of albumin, which has a similar size to the Upases but has a lymph concentration of 30% to 40% of plasma. Lipoprotein lipase activity In peripheral lymph and skeletal muscle lymph was 2.7% and 4.8%, respectively, of plasma activity. Since lipoprotein lipase has a similar size as hepatic triacylglycerol lipase, the disproportionate amount of lipoprotein lipase In lymph as compared to hepatic triacylglycerol lipase could be due to heparin crossing the capillary ondothollum and displacing lipoprotein lipase from peripheral cells. Injection of radioactive heparin confirmed that It does cross Into the interstitial space In sufficient concentrations to displace lipase from peripheral cells. We conclude that most of the lipase found In lymph after heparin Injection Is derived from peripheral cells and not from plasma. Furthermore, hepatic triacylglycerol lipase does not play a role In high density lipoprotein remodeling In interstitial fluid. Therefore, it seems likely that the considerable remodeling of high density lipoprotein that we found previously results from its Interaction with peripheral cells.
L ipoprotein lipase (LPL) and hepatic triacylglycerol lipase (HTL) are two enzymes of similar molecular weight (approximately 60 000 Da) that are responsible for the metabolism and remodeling of lipoprotein lipids within the circulating plasma. 1 The function of these enzymes within the plasma compartment has been studied in great detail. 2 -6 It is generally believed that LPL is a triacylglycerol lipase and that HTL is mainly a phospholipase with a specificity for high density lipoproteins (HDL). 67 Recently, cDNA clones of both enzymes have been successfully propagated and identified. From the cDNA sequence, the amino acid sequence has been deduced. 89 While the lipid-binding portions of the lipases are relatively conserved among HTL, LPL, and pancreatic lipase, other parts of their amino acid sequence are less conserved. 9 This is also reflected in the observation that antibodies to LPL and HTL do not cross-react with each other.
While lipoproteins and their metabolism have been studied in greater and greater detail in the circulatory system, much less is known about their actions in the interstitial space. The interstitial space has a larger volume than that of the circulatory space and forms the local environment of peripheral cells. Little is known about the role of LPL and HTL in the metabolism of lipoproteins in the interstitial fluid. Specifically, are these two enzymes present in the interstitial fluid? Are there specific activators or inhibitors in the interstitial fluid to these lipases? Finally, could these two lipases cross from plasma into the interstitial space?
Our laboratory has previously used the prenodal peripheral lymph in dogs as a model for interstitial fluid.
11 - 14 We have noted that the HDL from these peripheral lymphs are much different from those of plasma, 111213 and we postulated that the difference is due to remodeling of the HDL Since lipases are the major enzymes responsible for remodeling of lipoproteins in the vascular space, we wondered if some of the remodeling that we had observed is due to lipases in the lymph.
In this article, we report evidence from two different peripheral microvascular beds (prenodal peripheral lymph and skeletal muscle lymph), which suggests that very little plasma-derived LPL and HTL crosses the capillary wall into the interstitial space. There are no specific inhibitors of lipase in the interstitial fluid. Postheparin LPL found in the interstitial space is probably the result of heparin crossing the interstitial space and displacing de novo synthesized LPL into the lymph. Finally, we will provide evidence to suggest that heparin is capable of crossing the interstitial space, although in much smaller amounts than would be predicted from its molecular size.
Methods

Materials
Radioactive nickel and sodium borohydride were purchased from New England Nuclear (Boston, MA). Unless otherwise stated, all other chemicals were purchased from Sigma Biochemical (St. Louis, MO). Solvents were purchased from Baker (Philipsburg, NJ). Liquid scintillation fluid was obtained from Amersham (Arlington Heights, IL). Sodium heparin injectable (from bovine lung, 1000 lU/mr) was obtained from LyphoMed Inc. (Melrose Park, IL). The heparin used had a measured molecular mass of approximately 10 000 Da. Purified milk lipoprotein lipase was a gift from George Melchior, The Upjohn Company, Kalamazoo, Ml.
Analytical Methods
Our lipase assay has been described previously. 15 The assay could detect lipase activity down to the release of 1 nmol of fatty acid per unit of time. This sensitivity was sufficient to detect 0.001% of the peak plasma LPL and HTL activity. For this study, the incubations were for 1 hour. To assay for HTL activity, all the reagents contained 1 M of NaCI. In addition, the pH was shifted to 8.6 from 8.2. Under normal conditions, 100 /J of a 1:200 dilution of postheparin plasma was used for the assay. Lymph was used either undiluted or at a 1 M0 dilution. For the assay of preheparin plasma, 100 jd of plasma was used undiluted. The activator used in LPL assays consisted of 25 id of a heat-inactivated plasma (in a total assay volume of 400 fii). Postheparin lipase was prepared by injecting 100 lU/kg body weight heparin intravenously into a dog and collecting the plasma 30 minutes after the heparin injection. LPL activity was calculated by subtracting postheparin lipolytic activity from HTL activity that was determined in the presence of 1 M of sodium chloride.
The tritiation of heparin was based on the method described by Hatton et al. 16 Briefly, 10 ml of heparin (1000 lU/ml) was incubated with 1 ml of 1 M Tris HCI (pH 8.0), 10 mCi of tritiated sodium borohydride, and 2.5 mg of sodium cyanoborohydnde for 4 hours at 25°C. The sample was then diluted with 1 ml of saline, and 2.5 ml each was filtered through PD-10 (Sephadex G-25) columns. The eluate was then dialyzed twice with 1 I each of saline. The tritiated heparin contained 600 lU/ml of heparin and had a radioactivity of 1.1 x 1 o 7 dpm/ml. After tritiation, the heparin was tested for its ability to displace lipases in the rat Radioactive and nonradioactive heparin released essentially identical amounts of the lipases. The heparin concentration was determined by the method of Smith et al.
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Collection of Lymph and Heparin Infusion
Peripheral lymph was collected by methods which have been described previously. 18 Control, heart worm- 19 Collection of peripheral lymph prevents it from contaminating femoral lymph and allows collection of lymph derived primarily from skeletal muscle. Small blebs of sodium fluorescein solution were placed directly under the surface of skeletal muscles exposed by an incision over the femoral triangle. This allowed direct visualization of individual skeletal muscle lymphatics and their union with the femoral lymphatic. In several experiments, injection of 50 /J of concentrated Evans blue dye solution into the dorsum of the paw almost immediately turned the peripheral lymph dark blue, while there was no detectable color change in simultaneously collected skeletal muscle lymph. In agreement with previous investigators, 1920 the total plasma protein concentration of skeletal lymph was higher than that of peripheral lymph. Lymph flows were approximately 1 ml/hr for skeletal muscle and 2 ml/hr for peripheral lymph.
For constant heparin infusion experiments, a priming dose of 100 lU/kg was administered to the dogs, followed by a constant infusion of 1.65 lU/kg/min for the duration of the experiment. All the experiments involving animals or animal surgery were reviewed and approved by the Animal Care and Use Committee of Louisiana State Medical Center.
Results
The LPL or HTL activities in the plasma and lymph of control dogs were below the detectable range of our assay. Lipase activity was detected both in plasma and lymph only after intravenous injection of heparin (100 lU/kg body weight). The plasma distributions of HTL and LPL activities were approximately equal.
To determine if there were any activators or inhibitors of lipase activity in peripheral or skeletal muscle lymph, we added them to lipases obtained from two sources: purified milk LPL and postheparin plasma from normal dogs. The data are summarized in Table 1 . When 100 jd of 1M00 dilution of dog postheparin lipolytic activity (PHLA) plasma was used (Table 1 , column 1) in the presence of 50 ^1 or 80 ^1 of undiluted lymph, no detectable difference in lipolytic activity was noted. When purified milk LPL was used, the presence of an activator of LPL (heat-inactivated plasma, 25 /il in a total assay volume of 400 fit) caused the milk lipase to hydrolyze 110 /imol of fatty acid per milliliter per hour (Table 1 , column 2) which was unchanged by the addition of lymph. Thus, it would appear that lymph contained no The values are the means of three determinations on three dogs and are given as /unoles of fatty acid released/ml/hr.
Postheparin lipotytlc activity (PHLA) was a combination of lipoprotein lipase and hepatic triacytgtycerol lipase. The activator was heat-inactivated plasma (25 /xl In a total assay volume of 400 id). In assaying PHLA 100 /xl of a 1:100 dilution of plasma was used. When lymph was added to the PHLA it was added undiluted. On the assumption that lymph lipoproteins are 10% of plasma, the amount of lymph added In this experiment was five to eight times that of plasma The amount of milk lipase was diluted to a concentration similar to that of 1 til of dog PHLA TIME(min) Figure 2 . Upoprotein lipase and hepatic triacykjlycerol lipase activities in the plasma of an animal undergoing a constant infusion of heparin. • = t h e plasma heparin level during the infusion period, O=the lipoprotein lipase activity in the plasma, and A=the plasma hepatic triacytgtycerol lipase activity in plasma. Note that there was a peak of lipase activity at 30 minutes after a plateau level of 9 fimcA fatty add release per millilrter per hour up to 150 minutes. In contrast the hepatic triacylglycerol lipase activity rose to a plateau level at 15 minutes and stayed constant during the remainder of the time. plasma PHLA peaked 30 minutes after heparin administration. However, there was a time delay before lymph lipolytic activities plateaued. Most of the lymph lipolytic activities were due to lipoprotein lipase activity. O=plasrna, A=peripheral lymph, and o=skeletal muscle lymph. This graph also illustrates the difficulties of determining lymph to plasma ratios under non-steady state conditions. inhibitors of lipase. Addition of lymph to the purified milk lipase increased lipase activities slightly (Table 1 , column 3). We then titrated the optimal amount of activators in the lymph and plasma using the purified milk lipase. When 10 /J of plasma was added to purified milk lipase, 3.35±0.46 /imol/ml/hr fatty acid was released. This is similar to the LPL activity when 100 y\ of lymph was added (3.45+0.13 jimol/ml/hr). We deduced from the above experiment that the concentration of activators of LPL in lymph is approximately 10% that of plasma.
After intravenous heparin injection, plasma lipase activities increased and peaked 30 minutes after the heparin injection (Figure 1) . However, lymph lipolytic activities did not peak until 60 to 90 minutes after the heparin injection. The peak plasma lipolytic activity was 12.47 /imol/ml/hr fatty acid hydrolyzed. The peak peripheral lymph lipase activity was 0.226 /tmol/ml/hr and that of skeletal muscle lymph, 0.791 ^mol/ml/hr. LPL activity accounted for most of the lymph lipolytic activities.
Valid measurements of lipase lymph/plasma concentration ratios require steady-state conditions. One method of achieving this is to maintain constant plasma heparin concentration. This approach was first used by Porte and Bierman 21 to study triacylglycerol turnover in humans. Preliminary experiments with "S-heparin demonstrated that the plasma half-life of heparin was 42 minutes. The decrease of plasma heparin concentration followed a single exponential decay. Therefore, a suitable infusion rate could be calculated to maintain plasma concentration relatively constant. The result of one such experiment is shown in Figure 2 . From the figure, it could be seen that a plasma heparin concentration of approximately 1 lU/ml was maintained from 15 to 150 minutes. Plasma LPL rose to a peak at 30 minutes and plateaued at 10 /tmol/ml/hr from 45 to 150 minutes. Plasma HTL levels were constant at a level of 7.28 /imol/ml/hr from 15 to 150 minutes.
When plasma heparin concentrations were stable, lipase activities in the lymph were monitored. In the peripheral lymph, the LPL activity increased steadily to 90 minutes before reaching a plateau. On the other hand, the HTL activity plateaued at 60 minutes. This observation was reproduced in three other dogs. The data are presented in Figure 3 . In contrast to the plasma lipase activities where LPL and HTL activities were similar, the LPL activity was approximately twice that of the HTL The other major interstitial fluid (skeletal muscle lymph) was next studied. Skeletal muscle lymph HTL activity was similar to that found in peripheral lymph during the constant infusion of heparin both in concentration and in the shape of the plateau (Figures 3 and 4) . A plateau was reached at 60 minutes into the constant infusion. The LPL activity, however, increased steadily and did not reach a plateau until 120 minutes after the start of the heparin The values are given as ^moles of fatty acid released/ml/hr and are the means± 1 SD of four different animals.
The protocol for the constant Infusion of heparin Is described In the Methods section. The levels of LPL and HTL activities were measured after the lipase levels reached a steady-state level (see Figures 2 to 4) .
LPL=lipoproteln llpase, HTL=hepatic triacylglycerol llpase, and L/P ratio=lymph to plasma ratio. TIME (min) Figure 5 . Heparin levels in the peripheral and skeletal muscle lymph of an animal undergoing a constant infusion of heparin in the plasma. In contrast to lipoproteins or albumin, the level of heparin in the skeletal muscle lymph was the same as that of the peripheral lymph. The lymph to plasma ratio Is 0.2. The molecular weight of the heparin used was approximately 10 000 Da.
•-heparin levels In plasma, •=heparin levels In the skeletal muscle lymph, and A=heparin levels In peripheral lymph. Note that the scale for the plasma heparin levels is plotted on the right axis.
infusion. The concentration of skeletal muscle LPL was twice as high as that of the peripheral lymph LPL and four times higher than the skeletal muscle lymph HTL lipase activity.
We were able to achieve plateau levels of LPL and HTL actJvities in both peripheral and skeletal muscle lymph and plasma during the constant heparin infusion. Therefore, we could calculate the lymph/plasma concentration ratios of the two Upases. The results are summarized in Table 2 . The lymph concentration for LPL was 2.7% of plasma for peripheral lymph and 4.8% of plasma for skeletal muscle lymph. The lymph HTL concentration was 1.4% of plasma for peripheral lymph and 1.1 % of plasma for skeletal muscle lymph.
Since both lipases have approximately the same size, one would expect similar lymph/plasma concentration ratios for the lipases in both lymph samples. One possible reason for greater LPL lymph concentration is that heparin may filter through to the interstitjum and displace nascent, de novo synthesized lipoprotein from the peripheral or skeletal muscle cells. To test this hypothesis, radioactive heparin was injected intravenously as a bolus and as an infusion to maintain a constant level of plasma heparin. These experiments were exactly the same as the constant infusion of heparin experiments described above except that radioactive heparin was substituted for nonradioactive heparin. Peripheral and skeletal muscle lymph were collected and monitored. The result shown in Figure 5 indicates that heparin crossed from the plasma into the interstitium. The concentration of heparin in lymph was 20% that of plasma.
At these plasma concentrations, the heparin concentration in peripheral and skeletal muscle lymph is insufficient to displace all LPL from the cell surface. Our preliminary experiments have shown that when heparin was injected into animals at 10 ILJ/kg (10 times less than the dose used in these experiments), not all the LPL was released (data not shown). Therefore, we suspected that there was more releasable LPL in the skeletal muscle lymph. To test this hypothesis, the plasma concentration The values are given as ^noles of fatty acid released/ml/hr and are the means±1 SD of three determinations. The animals were maintained on a constant infusion of heparin. During this period of time (150 to 210 minutes), their llpase activities reached a plateau in both the plasma and the lymph. At the end of the constant infusion, a bolus of heparin was injected (500 lU/kg), and lymph collection was maintained for 1 hour. LJpase activities in the plasma and lymph were measured.
LPL=lipoprotein lipase, HTL=hepatic triacyiglycerol lipase.
of heparin was raised to 5 lU/ml at the end of a constant heparin infusion experiment by a bolus injection of heparin, and the peripheral and skeletal muscle lymph collection was extended for 1 hour. After this bolus injection, plasma LPL and HTL activities remained static. In the peripheral lymph, there was no substantial increase in either lipase activity. The skeletal muscle lymph HTL activity was also constant. In contrast, the skeletal muscle lymph LPL activity tripled. The results are summarized in Table 3 . This experiment demonstrated that increased plasma levels of heparin could increase the skeletal muscle lymph lipase concentration, thus further strengthening our hypothesis that heparin crosses into the interstitial space from plasma.
Discussion
We have previously described the concentration of lipoproteins and apolipoproteins in the interstitial fluid of both control and cholesterol-fed dogs.
11 - 14 The concentrations of apolipoprotein (apo) B containing particles are 2% to 7% of their plasma counterparts. 22 In general, these values agreed with those observed by Reichl and coworkers 232425 in their studies of human interstitial fluid. Interstitial HDL is present in 10% to 19% of its plasma concentration. It is enriched in free cholesterol, and at least some of the HDL is discoidal in nature. 1213 Although the peripheral lymph model is considered a good model for interstitial fluids, it represents approximately 30% to 40% of the total interstitial space (skin and connective tissues). In this study, we extended the model to include lymph derived from skeletal muscle, which represents another 30% to 40% of total interstitial space. Thus, taken together, data derived from peripheral and skeletal muscle lymph should be representative of most of the interstitial space.
Upoproteins in the vasculature are constantly being remodeled through their interaction with LPL or HTL. 1 Thus, very low density lipoprotein (VLDL) will be remodeled through the action of LPL, and HDL will be remodeled through the action of HTL During this remodeling, part of the VLDL phospholipid transfers to form HDL Little is known about the presence or absence of lipases in the interstitial space. Reichl and his coworkers 26 were not able to detect any LPL activity when heparin was not introduced in human peripheral lymph. These data agree with our findings. However, postheparin LPL activity in dog cardiac lymph has been reported to reach 10% to 30% that of plasma. 27 Since our previous articles suggest considerable remodeling of HDL in the interstitial space, we thought it important to determine if some of this remodeling could be due to interactions of lipoproteins with lipases. As we could not find any lipase activities in lymphs of dogs not injected with heparin, we wondered whether this could be due to the presence of inhibitors of lipase activities in the lymph. Our experiments, summarized by Table 1 , suggest that there were no inhibitors to either LPL or HTL However, there were activators of LPL and their concentration was 10% of plasma.
After a bolus injection of heparin, lipase activities could be detected in both the peripheral and skeletal muscle lymph. However, the activities were lower than expected for molecules of the size of both lipases. The data, summarized by Figure 1 and Table 1, suggest that activators or inhibitors were not present to cause this low level of lipase activity. The data also illustrate the difficulties of trying to calculate lymph concentrations of lipase as a fraction of plasma, since the lipases peak and decay at different rates.
During the constant infusion of heparin, there was an initial surge of plasma LPL activity. The lipase activity peaked at 30 minutes and then fell to a steady-state level (see Figure 2 ). These data indicate that the injection of heparin caused an initial release of LPL from all sources linked by the vasculature. This initial release was followed by a rapid uptake of the LPL After this event, the level of LPL remained constant. This would imply, although it does not prove, that the rate of removal and the release of LPL are in steady state. HTL activity also remained constant at a steady level during the period of constant infusion (Figure 2) . Therefore, the rate of removal must also be in rough equilibrium with the rate of release. Porte and Bierman 21 had similar findings in PHLA in human subjects that were being given a constant infusion of heparin.
Since we were able to maintain relatively constant levels of lipase activity in both the peripheral and skeletal muscle lymph (Figures 3 and 4) , we were able to calculate lymph lipase concentrations as a fraction of plasma concentrations. Based on their molecular size and the known albumin concentration in lymph (30% to 40% of plasma), we expected much higher concentrations of lipase activities in the peripheral lymph and skeletal muscle lymph. In actuality, the lymph to plasma (l/p) ratio for HTL was relatively constant for both skeletal and peripheral lymph. However, the actual concentrations were only 1.1 % and 1.4% of plasma, 40-fold less than had been expected (Table 2 ). There is evidence that LPL may exist as a dimer in solution. 28 In postheparin plasma, it probably exists as a complex with heparin, thereby making the actual size of LPL closer to that of HDL (200 000 Da). It is likely that HTL may behave the same way. The concentration of apo A-l in peripheral lymph is 15% to 20% that of plasma 11 Therefore, either LPL or HTL is larger than low density lipoprotein (apo B in lymph is 5% to 8% of plasma 11 ), or factors other than molecular sieving are responsible for the transport of extremely small amounts of HTL from the vascular space into the interstitial space. Our finding that there are undetectable levels of either LPL or HTL in the control dog makes it likely that neither enzyme is responsible for the extensive remodeling of interstitial HDL The concentration of LPL is somewhat higher than that of HTL in the lymph. They are 2.7% and 4.8%, respectively, of plasma in the peripheral and skeletal muscle lymph (Table 2 ). This level is still not the 30% to 40% concentration of plasma that was expected if albumin is used as a guide, nor the 15% to 20% if apo A-l is used. Again, factors other than molecular sieving must be at work to account for plasma's low interstitial concentrations. The most likely explanation for the inability of the Upases to permeate the interstitial space is that the lipases are trapped by the gtycocatyx at the surface of the vasculature. If LPL, like HTL, is relatively impermeable, then the somewhat higher levels of LPL l/p ratio needs explanation. This is especially true in the skeletal muscle lymph. A number of investigators have found that LPL can be synthesized by skeletal muscle 29 and adipose tissue. 1 Therefore, it was our hypothesis that the somewhat higher concentrations of LPL found in the skeletal muscle lymph and peripheral lymph were due to heparin crossing the interstrtium and displacing the de novo synthesized LPL. To test this hypothesis, radioactive heparin was infused into dogs in constant infusion experiments. The results shown in Figure 5 demonstrate that heparin does indeed penetrate the capillary wall and enter the interstitial space.
The concentration of heparin in lymph was 20% that of plasma. This value is nearly five times lower than expected since the molecular mass of heparin is 10 000 Da. Even assuming that heparin does exist as a rigid rod and not a folded-up globular protein, the "effective" size could not be 20 times (the size of HDL as determine by apo A-l) more than the actual size. Again, factors other than sieving, such as trapping by the glycocatyx, must be at work. This concentration of heparin was insufficient to displace all LPL in the interstitial space. Therefore, a fivefold concentration of heparin was introduced into the plasma in some later constant infusion experiments. As predicted, the level of LPL rose in the skeletal muscle lymph. LPL concentration did not increase in the plasma or peripheral lymph (Table 3) .
Taken together, our results demonstrate that LPL exists in bound form in the interstrtium. HDL is probably not remodeled to any great extent by lipases within the interstitial space as a result of interactions with HTL Therefore, it seems likely that most of the modifications of lymph HDL result from its interaction from peripheral cells.
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